 Comparative analysis of mergers and acquisitions in Indian and international pharmaceutical industry with unique case-letsSom Sekhar Bhattacharyya and Syed Naser International Journal of Business and Globalisation, 2020, vol. 25, issue 1, 112-136 Abstract: Mergers and acquisitions (M%A) have become a potent strategy for firms to secure inorganic growth but are also beset with challenges. Pharmaceutical industry has a unique nature due to higher involvement of science in product development and requires firms to develop distinctive and complex capabilities. In this study, the authors undertake a comparative study of different pharmaceutical cases to gather perspectives on M%A practices in Indian and international pharmaceutical industry. Frameworks developed by Bower (2001) and Dyer et al. (2004) are applied to different M%As to understand their applicability and use in Indian and international pharmaceutical contexts. The authors found that Indian firms undertake M%A to reduce R%D investments, to secure strategic resources and to expand product and market reach. Pharmaceutical firms from developed countries mostly acquire firms from developing market for sake of manufacturing knows how and for securing host market. Keywords: mergers and acquisition; M%A; Indian pharmaceutical industry; international pharmaceutical industry; business performance. (search for similar items in EconPapers) Downloads: (external link) Related works: Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text Persistent link: https://EconPapers.repec.org/RePEc:ids:ijbglo:v:25:y:2020:i:1:p:112-136 Access Statistics for this article More articles in International Journal of Business and Globalisation from Inderscience Enterprises Ltd |
Is your work missing from RePEc? Here is how to contribute.
Questions or problems? Check the EconPapers FAQ or send mail to .
EconPapers is hosted by the
School of Business at Örebro University.